hear.com N.V. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| hear.com N.V. | HCG - NASDAQ |
Postponed | $0.00 | $0.00 | Postponed | 5/14/2021 |
| Morgan Stanley, JP Morgan, Deutsche Bank, Goldman Sachs | ||||||
Co-Manager(s): BofA Securities, William Blair, Truist Securities
| ||||||
| Health Care | ||||||
Filing(s): Filed 2021-04-19 Terms Added 2021-05-05 | ||||||
About hear.com N.V. (adapted from hear.com N.V. prospectus):
They have grown rapidly to become the largest online provider of expert, medical-grade hearing care globally.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They have grown rapidly to become the largest online provider of expert, medical-grade hearing care globally.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "HCG" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.